SCHEMBL5828209

SCHEMBL5828209

NNn1cnc2cncnc21

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.40
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
LTA4H P09960 1/20 0.34
ALDH1A1 P00352 4/20 0.33
CYP1A2 P05177 4/20 0.33
CYP2C19 P33261 4/20 0.33
LMNA P02545 3/20 0.33
TSHR P16473 3/20 0.33
CYP3A4 P08684 3/20 0.33
CYP2C9 P11712 3/20 0.33
MEN1 O00255 1/20 0.33
HBB P68871 1/20 0.33
KMT2A Q03164 1/20 0.33
MKNK2 Q9HBH9 1/20 0.33
USP2 O75604 2/20 0.32
EGFR P00533 2/20 0.32
CYP2D6 P10635 1/20 0.31
CLK4 Q9HAZ1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9356692 0.81 FDPS (0.40) FDPSHDAC1HDAC6LTA4HALDH1A1
SCHEMBL3021750 0.81 FDPS (0.40) FDPSHDAC1HDAC6LTA4HALDH1A1
SCHEMBL3421967 0.81 FDPS (0.46) FDPSHDAC1HDAC6LTA4HALDH1A1
SCHEMBL27930861 0.78 FDPS (0.38) FDPSHDAC1HDAC6LTA4HALDH1A1
SCHEMBL27337608 0.78 HDAC1 (0.42) FDPSHDAC1HDAC6LTA4HALDH1A1
SCHEMBL5041084 0.77 FDPS (0.37) FDPSHDAC1HDAC6LTA4HALDH1A1
SCHEMBL5436672 0.77 FDPS (0.37) FDPSHDAC1HDAC6LTA4HALDH1A1
SCHEMBL4859275 0.77 FDPS (0.37) FDPSHDAC1HDAC6LTA4HALDH1A1
SCHEMBL2789824 0.75 CYP1A2 (0.36) FDPSHDAC1HDAC6LTA4HALDH1A1
SCHEMBL7035233 0.75 FDPS (0.37) FDPSHDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112912378-B Hydrazinopurine compounds and triazolopurine compounds for inhibiting xanthine oxidase 泰拉强石株式会社 2023-09-12 CN claimed
US-20210347778-A1 HYDRAZINOPURINE COMPOUND AND TRIAZOLOPURINE COMPOUND FOR INHIBITING XANTHINE OXIDASE TERA STONE CO., LTD (JP) 2021-11-11 US claimed
EP-3845535-A1 HYDRAZINOPURINE COMPOUND AND TRIAZOLOPURINE COMPOUND FOR INHIBITING XANTHINE OXIDASE Tera Stone Co., Ltd (JP) 2021-07-07 EP claimed
CN-112912378-A Hydrazinopurine compounds and triazolopurine compounds for inhibiting xanthine oxidase 泰拉强石株式会社 2021-06-04 CN claimed
WO-2020045558-A1 HYDRAZINOPURINE COMPOUND AND TRIAZOLOPURINE COMPOUND FOR INHIBITING XANTHINE OXIDASE テラ・ストーン株式会社 2020-03-05 WO claimed
US-7034016-B2 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i]purin-5-one derivatives ALMIRALL PRODESFARMA, S.A. (ES) 2006-04-25 US claimed
EP-1198464-B1 8-PHENYL-6,9-DIHYDRO-[1,2,4]TRIAZOLO[3,4-i]PURIN-5-ONE DERIVATIVES ALMIRALL PRODESFARMA SA (ES) 2003-10-08 EP claimed
US-20030060627-A1 8-Phenyl-6, 9-dihydro-[1,2,4] triazolo[3,4-i]purin-5-one derivatives ALMIRALL PRODESFARMA, S.A. (ES) 2003-03-27 US claimed
EP-1198464-A1 8-PHENYL-6,9-DIHYDRO- 1,2,4]TRIAZOLO 3,4- i i /i ]PURIN-5-ONE DERIVATIVES Almirall Prodesfarma, S.A. (ES) 2002-04-24 EP claimed
WO-2001007441-A1 8-PHENYL-6,9-DIHYDRO-[1,2,4]TRIAZOLO[3,4-i]PURIN-5-ONE DERIVATIVES ALMIRALL PRODESFARMA S.A. (ES) 2001-02-01 WO claimed
EP-3845535-B1 HYDRAZINOPURINE COMPOUND AND TRIAZOLOPURINE COMPOUND FOR INHIBITING XANTHINE OXIDASE TERA STONE CO LTD (JP) 2024-06-26 EP disclosed
CN-112912378-B Hydrazinopurine compounds and triazolopurine compounds for inhibiting xanthine oxidase 泰拉强石株式会社 2023-09-12 CN disclosed
CN-112912378-B Hydrazinopurine compounds and triazolopurine compounds for inhibiting xanthine oxidase 泰拉强石株式会社 2023-09-12 CN disclosed
JP-2023071839-A HYDRAZINOPURINE COMPOUND AND TRIAZOLOPURINE COMPOUND FOR INHIBITING XANTHINE OXIDASE テラ・ストーン株式会社 2023-05-23 JP disclosed
US-20210347778-A1 HYDRAZINOPURINE COMPOUND AND TRIAZOLOPURINE COMPOUND FOR INHIBITING XANTHINE OXIDASE TERA STONE CO., LTD (JP) 2021-11-11 US disclosed
US-7034016-B2 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i]purin-5-one derivatives ALMIRALL PRODESFARMA, S.A. (ES) 2006-04-25 US disclosed
EP-1198464-B1 8-PHENYL-6,9-DIHYDRO-[1,2,4]TRIAZOLO[3,4-i]PURIN-5-ONE DERIVATIVES ALMIRALL PRODESFARMA SA (ES) 2003-10-08 EP disclosed
US-20030060627-A1 8-Phenyl-6, 9-dihydro-[1,2,4] triazolo[3,4-i]purin-5-one derivatives ALMIRALL PRODESFARMA, S.A. (ES) 2003-03-27 US disclosed
EP-1198464-A1 8-PHENYL-6,9-DIHYDRO- 1,2,4]TRIAZOLO 3,4- i i /i ]PURIN-5-ONE DERIVATIVES Almirall Prodesfarma, S.A. (ES) 2002-04-24 EP disclosed
WO-2001007441-A1 8-PHENYL-6,9-DIHYDRO-[1,2,4]TRIAZOLO[3,4-i]PURIN-5-ONE DERIVATIVES ALMIRALL PRODESFARMA S.A. (ES) 2001-02-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030060627-A1 8-Phenyl-6, 9-dihydro-[1,2,4] triazolo[3,4-i]purin-5-one derivatives HYOU1, CHN2, PURB FDPS 4023/4885HDAC1 1248/4885HDAC6 2147/4885
US-20210347778-A1 HYDRAZINOPURINE COMPOUND AND TRIAZOLOPURINE COMPOUND FOR INHIBITING XANTHINE OXIDASE XDH, HPRT1, TPMT FDPS 855/4885HDAC1 327/4885HDAC6 930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.